Adjuvant chemotherapy in rectal cancer-an issue or a nonissue?

Annals of Oncology

Volumn 21, Issue 9, 2010, Pages 1739-1741

  Glimelius, B ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; COLORECTAL SURGERY; DISEASE FREE SURVIVAL; EDITORIAL; HUMAN; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREOPERATIVE CARE; PRIORITY JOURNAL; RECTUM CANCER; RECURRENCE RISK; TREATMENT INDICATION;

EID: 77956103446     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq263     Document Type: Editorial

References (23)

1. Punt CJ, Buyse M, Kohne CH et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 2007; 99: 998-1003.
2. Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998; 16: 1380-1387.
3. Knops AM, Goossens A, Burger MP et al. A tool to balance benefit and harm when deciding about adjuvant therapy. Br J Cancer 2009; 100: 913-917.
4. Andre T, Boni C, Navarro M et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109-3116.
5. Wolmark N, Wieand S, Kuebler PJ et al. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: survival results of NSABP Protocol C-07 2008; ASCO Annual Meeting 2008; LBA4005 abstr.
6. Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 2008; issue 3: CD005390.
7. Sjovall A, Granath F, Cedermark B et al. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol 2007; 14: 432-440.
8. Pahlman L, Bohe M, Cedermark B et al. The Swedish rectal cancer registry. Br J Surg 2007; 94: 1285-1292.
9. Bujko K, Glynne-Jones R, Bujko M. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radio(chemo)therapy? A systematic review of randomized trials. Ann Oncol 2010; 21: 1743-1750.
10. NCI. Clinical Announcement. Adjuvant Therapy of Rectal Cancer. National Cancer Institute, Bethesda, MD, 1991.
11. Glimelius B. Chemoradiotherapy for rectal cancer-is there an optimal combination? Ann Oncol 2001; 12: 1039-1045.
12. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
13. Valentini V, Aristei C, Glimelius B et al. Multidisciplinary rectal cancer management. Radiother Oncol 2009; 92: 148-163.
14. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-987.
15. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al. Preoperative radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer. Report from a multicenter randomized trial. New Engl J Med 2001; 345: 638-646.
16. Sebag-Montefiore D, Stephens RJ, Steele R et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811-820.
17. Glimelius B. Pre-or postoperative radiotherapy in rectal cancer - more to learn?. Radiother Oncol 2001; 61: 1-5.
18. Sakamoto J, Hamada C, Yoshida S et al. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. Br J Cancer 2007; 96: 1170-1177.
19. Glimelius B, Dahl O, Cedermark B et al. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol 2005; 44: 904-912.
20. Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
21. Collette L, Bosset JF, den Dulk M et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy?. J Clin Oncol 2007; 25: 4379-4386.
22. Quasar Collaborative Group, Gray R, Barnwell J et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370: 2020-2029.
23. James RD, Donaldson D, Gray R et al. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS). Br J Surg 2003; 90: 1200-1212.